M&A / Deals Asahi Kasei acquires German company Aicuris Pharmaceutical TechnologyAsahi Kasei has completed its acquisition of Aicuris Anti-infective Cures, a German biopharmaceutical company.M&A / DealsRead full story pharminent April 21, 2026 (Last updated: April 21, 2026) Pharmaceutical Technology Asahi Kasei has completed its acquisition of Aicuris Anti-infective Cures, a German biopharmaceutical company. M&A / DealsRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Trump executive order lifts psychedelics biotechsNext: Italy leads the way on child genetic disease diagnosis Related Stories M&A / Deals J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout pharminent July 31, 2026 M&A / Deals Eisai and CORE Biomedicine agree on global licence for oncology pipeline pharminent July 29, 2026 M&A / Deals Argenx signs agreement to buy Forte Biosciences for $2.2bn pharminent July 28, 2026
